Nihon Kohden Corporation

Equities

6849

JP3706800004

Advanced Medical Equipment & Technology

Delayed Japan Exchange Other stock markets 11:30:00 28/05/2024 am IST			5-day change	1st Jan Change
4,631 ^JPY	+0.41%		+5.13%	+3.76%

13/05	Nihon Kohden Corporation announces an Equity Buyback for 6,000,000 shares, for ¥10,000 million.	CI
13/05	Nihon Kohden Corporation authorizes a Buyback Plan.	CI

Nihon Kohden Corporation Provides Consolidated Earnings Guidance for the Year Ending March 31, 2021

August 04, 2020 at 11:30 am IST

Nihon Kohden Corporation provided consolidated earnings guidance for the year ending March 31, 2021. For the year, the company expects consolidated net sales of JPY 180,000 million, operating income of JPY 14,000 million, income attributable to owners of parent of JPY 10,000 million or JPY 117.43 per basic share.

Latest news about Nihon Kohden Corporation

Nihon Kohden Corporation announces an Equity Buyback for 6,000,000 shares, for ¥10,000 million.	13/05	CI
Nihon Kohden Corporation authorizes a Buyback Plan.	13/05	CI
Japanese Shares End in Green as Yen Weakens	27/03	MT
Nihon Kohden to Book Extraordinary Gains of 4 Billion Yen in Fiscal Q4 Following Adjustment in Retirement Plan	27/03	MT
Nihon Kohden Repurchases 1.1 Billion Yen Worth of Shares	06/02	MT
Tranche Update on Nihon Kohden Corporation's Equity Buyback Plan announced on February 2, 2024.	05/02	CI
Nihon Kohden Corporation's Equity Buyback announced on February 2, 2024, has closed with 250,000 shares, representing 0.3% for ¥1,123.75 million.	05/02	CI
Nihon Kohden Corporation announces an Equity Buyback for 250,000 shares, representing 0.3% for ¥1,123.75 million.	02/02	CI
Nihon Kohden Corporation authorizes a Buyback Plan.	02/02	CI
Nihon Kohden Corporation Sets New Standard for Central Nursing with the Launch of CNS-2101	19/12	CI
Nihon Kohden Corporation Provides Final Dividend Guidance for the Fiscal Year Ending March 31, 2024	08/11	CI
Nihon Kohden Corporation Announces Interim Second Quarter Dividend for the Fiscal Year Ending March 31, 2024	08/11	CI
Nihon Kohden Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	08/11	CI
Nihon Kohden Corp Revises Forecast for Fiscal H1 Upwards to Reflect Stronger Sales, Weaker-than-Expected Yen	19/23/19	MT
Nihon Kohden Corporation Revises Consolidated Earnings Guidance for the First Half Ended September 30, 2023	18/23/18	CI
Nihon Kohden Corporation Unveils Groundbreaking One View Solution Powered by the Neuromaster G1 for Vital Signs Integration in Intraoperative Neuromonitoring	11/23/11	CI
Nihon Kohden Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of the Fiscal Year Ending March 31, 2024	03/23/03	CI
Nihon Kohden Disposes of Treasury Stock as Restricted Stock Remuneration	01/23/01	MT
Nihon Kohden to Dispose of Treasury Stock as Restricted Stock Remuneration	05/23/05	MT
Nihon Kohden Corporation Reports Earnings Results for the Full Year Ended March 31, 2023	15/23/15	CI
Nihon Kohden Corporation Provides Consolidated Earnings Guidance for the First Half of Fiscal Year 2023 and Fiscal Year Ending March 31, 2024	15/23/15	CI
Nihon Kohden Corporation Provides Year End Dividend Guidance for the Year Ending March 31, 2024	15/23/15	CI
Nihon Kohden Corporation Announces Year-End Dividend for the Fiscal Year Ended March 31, 2023; Provides Interim Second Quarter Dividend Guidance for the Fiscal Year Ending 2023	15/23/15	CI
Nihon Kohden Corporation Proposes Dividend Guidance for the Year Ending March 31, 2023	28/23/28	CI
Nihon Kohden Corporation Revises Earnings Guidance for the Year Ending March 31, 2023	28/23/28	CI

Chart Nihon Kohden Corporation

Duration

Period

More charts

Company Profile

NIHON KOHDEN CORPORATION is a Japan-based company engaged in the research, development, manufacture and sale of medical electronic equipment, as well as the provision of maintenance and repair services. The Company mainly operates medical electronics related business. The Company offers electroencephalograph, electromyographic, evoked potential testing equipment, electrocardiographs, cardiac catheterization equipment, diagnostic information systems and related consumables (paper, electrodes, catheters and others), biological information monitors, clinical information systems, artificial respiration, artificial ear, hemocytometer, ultrasonic diagnostic equipment, research equipment and transformers, among others. The Company is also engaged in the sales promotion for its products, as well as the general affair-related and manpower dispatching businesses.

Sector

Advanced Medical Equipment & Technology

Calendar

27/06/2024 - Split: 2 of 1

More about the company

Income Statement Evolution

More financial data

Ratings for Nihon Kohden Corporation

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

4,612 JPY

Average target price

4,378 JPY

Spread / Average Target

-5.07%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
NIHON KOHDEN CORPORATION	+3.76%	2.47B
THERMO FISHER SCIENTIFIC	+10.03%	223B
DANAHER CORPORATION	+13.59%	195B
INTUITIVE SURGICAL, INC.	+20.01%	144B
BOSTON SCIENTIFIC CORPORATION	+30.83%	111B
SIEMENS HEALTHINEERS AG	+2.51%	65.19B
EDWARDS LIFESCIENCES CORPORATION	+15.38%	53.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+3.64%	50.28B
AGILENT TECHNOLOGIES, INC.	+8.37%	44.15B
GE HEALTHCARE TECHNOLOGIES INC.	+3.27%	36.45B

Other Advanced Medical Equipment & Technology